ライフサイエンスコーパス: bacterial antigen

1 the presence of microbial RNA sequences and bacterial antigen.

2 ibute to the enhanced T-cell response to the bacterial antigen.

3 lar to the aggregation observed for purified bacterial antigen.

4 ming of CD8(+) T cells against a nonsecreted bacterial antigen.

5 cond T-cell receptor (TCR) that recognizes a bacterial antigen.

6 may reduce risk of endothelial activation by bacterial antigens.

7 ripheral blood mononuclear cell responses to bacterial antigens.

8 not IgG antibody, recognizing T-independent bacterial antigens.

9 unt T-independent antibody responses against bacterial antigens.

10 ells independently of cognate recognition of bacterial antigens.

11 polyreactive and frequently bound to host or bacterial antigens.

12 multiple immune effectors targeting multiple bacterial antigens.

13 l trafficking of CD11b+ cells in response to bacterial antigens.

14 ulated immune responses against intraluminal bacterial antigens.

15 rently are associated with a Th1 response to bacterial antigens.

16 ntibodies in SLE may be elicited by the same bacterial antigens.

17 a dysregulated immune response to ubiquitous bacterial antigens.

18 predominantly reactive toward Staphylococcal bacterial antigens.

19 and TLR4 by gram-positive and gram-negative bacterial antigens.

20 alpha-defensins in response to bacteria and bacterial antigens.

21 3 days of a primary response to particulate bacterial antigens.

22 bicidal peptides when exposed to bacteria or bacterial antigens.

23 cultured with splenocytes in the presence of bacterial antigens.

24 Adoptive transfer of bacterial-antigen-activated CD4+ T cells from colitic C3

25 Identification of the initiating bacterial antigen and a cross-reactive autoantigen may p

26 These results suggested that GEC can take up bacterial antigen and consequently process and present t

27 weak homology with a fragment of a putative bacterial antigen and, like that molecule, binds IgG.

28 onse, which primarily targeted gram-negative bacterial antigens and conferred protection against syst

29 tributions to protective efficacy of various bacterial antigens and host immune effectors.

30 -PC is cross-reactive with a variety of oral bacterial antigens and human antigens such as oxidized l

31 Bacterial antigens and IL-2 increased HIV-1 replication;

32 Activation is induced by stimulation from bacterial antigens and inflammatory cytokines derived fr

33 eting NK cells resulted in the expression of bacterial antigens and iNOS outside the granulomas and t

34 utoreactivity and instead target both shared bacterial antigens and specific bacterial strains.

35 ed that exposure to lipopolysaccharide (LPS, bacterial antigen) and polyinosinic-polycytidylic acid (

36 ure, Gram stain, and latex agglutination for bacterial antigen) and qPCR for Streptococcus pneumoniae

37 e to innate immunity by sensing bacteria and bacterial antigens, and discharge microbicidal peptides

38 ed after incubation with cytokines, food and bacterial antigens, and homogenates of small and large b

39 f antigen compartmentalization suggests that bacterial antigens are presented by multiple MHC class I

40 T cells that specifically recognize viral or bacterial antigens are selected to survive and prolifera

41 Abs did not show cross-reactivity with other bacterial antigens as confirmed by IgG ELISA, further va

42 ed synthesis of the glucosyl analogue of the bacterial antigen BbGL-II.

43 igger potent humoral and T-cell responses to bacterial antigens by recruiting, reprogramming and rele

44 The data support the hypothesis that a bacterial antigen can break immune tolerance in vivo, an

45 Alternatively, specific bacterial antigens can drive a distinct set of adaptive

46 increased inflammatory cell mobilization and bacterial antigen clearance from the inflamed colon to t

47 matory responses to common upper respiratory bacterial antigens compared to those of cells derived fr

48 Thus, the gp41 commensal bacterial antigen cross-reactive antibodies originate in

49 odies from vaccinees can be instrumental for bacterial antigen discovery.

50 g cell population that mediated tolerance to bacterial antigens during a defined developmental window

51 is in the face of dynamic shifts in food and bacterial antigens during development.

52 Vaccines based on preferential expression of bacterial antigens during human infection have not been

53 d BALB/c mice are Th2 cytokine responsive to bacterial antigen early after challenge with P. aerugino

54 Upon stimulation by bacterial antigens, enteric alpha-defensins are secreted

55 s has only rarely been demonstrated toward a bacterial antigen from a naturally occurring human infec

56 en as mediated by FcRn involves retrieval of bacterial antigens from the lumen and initiation of adap

57 induce mucosal immune responses against key bacterial antigens has been a continuing focus of invest

58 The persistence of bacterial antigen in arthritic tissue and the isolation

59 In the study they expressed a bacterial antigen in maize seed and obtained aberrant lo

60 ies identify antigen processing of a natural bacterial antigen in the human CD1c system, indicating t

61 sing human corneal epithelial multilayers to bacterial antigens in a culture supernatant (known to up

62 us peptides as minor H antigens and foreign, bacterial antigens in a defensive immune response to inf

63 ificantly alters the murine host response to bacterial antigens in an in vitro coculture system.

64 IgE antibodies directed to bacterial antigens in HDM were quantified by IgE ImmunoC

65 The findings of bacterial antigens in the joint and persistent triggerin

66 but distinct processes maintain tolerance to bacterial antigens in the large intestine.

67 se could affect the immune response to other bacterial antigens in the oral cavity.

68 dal peptide activity in response to purified bacterial antigens, including lipid A.

69 pid activation of macrophages in response to bacterial antigens is central to the innate immune syste

70 ve T cells expanded by reacting with luminal bacterial antigens is likely caused by the survival of t

71 s to investigate whether HDM are carriers of bacterial antigens leading to IgE sensitization in patie

72 Pups injected with the bacterial antigen lipopolysacchride (LPS; 75 mug/kg body

73 Candida albicans, mumps, Trichophyton, and a bacterial antigen made from lysed Staphylococcus aureus.

74 thesis" theorizes that decreased exposure to bacterial antigens may trigger autoimmunity.

75 of this study was to determine whether these bacterial antigens might be involved in HL60 cells cytol

76 Persistence of bacterial antigens might initiate a cascade of cellular

77 to whole bacterial cells and to heat-stable bacterial antigens of all seven prototypic P. aeruginosa

78 reptococcus pyogenes to study the effects of bacterial antigens on the emergent B-1 B cell clonal rep

79 re activated in vivo after exposure to these bacterial antigens or bacteria, and mice that lack NKT c

80 g immunohistochemical analysis, we localized bacterial antigens primarily to lymphoid tissues and liv

81 The correlation between bacterial antigen production and infection stage was inv

82 phic nature of M3 and its ability to present bacterial antigens rapidly and dominantly make it an att

83 0 CD4 cells/mm3, Vdelta2 T cell responses to bacterial antigens remain intact.

84 ted within human dendritic cells showed that bacterial antigens remained intact, even after delivery

85 Studies determined that the bacterial antigen responsible for this pro-viral activit

86 gic airway inflammation or the TH17-inducing bacterial antigen Saccharopolyspora rectivirgula in a mo

87 n decreased SC and IgA antibodies to certain bacterial antigens (SAEB) in nasal secretions of patient

88 These include specific recognition of bacterial antigens, specific recognition of autoantigens

89 Colitis was induced by transfer of a cecal bacterial antigen-specific C3H/HeJBir (C3Bir) CD4(+) T-c

90 lungs, liver, spleen, and brain and induced bacterial antigen-specific immune responses.

91 ells, although augmentation or inhibition of bacterial antigen-specific T cell responses does not alt

92 ation, we characterized disease kinetics and bacterial antigen-specific T-cell responses in ex germ-f

93 ted amounts of IL-12 and TNF-alpha following bacterial antigen stimulation, indicating alternative pa

94 Mucosal sites exposed to a high load of bacterial antigens--such as the periodontium, lung, and

95 lasting elevation of antibodies to commensal bacterial antigens, suggesting that MCMV infection may h

96 broth cultures, 5,218, $4,931, and 80 h; and bacterial antigen tests, 2,598, $2,293, and 299 h.

97 F from patients with shunts; and eliminating bacterial antigen tests.

98 ation under caries appears to be elicited by bacterial antigens that diffuse into the pulp through de

99 direct T-cell expression cloning to identify bacterial antigens that induce a preferential or biased

100 Despite containing the same bacterial antigens, the reported nanotoxoid formulation

101 e responses against blood-born T-independent bacterial antigens (TI), but the full scope of their imm

102 gen and consequently process and present the bacterial antigen to CD4(+) T cells by MHC class II in c

103 by rapidly clearing bacteria and presenting bacterial antigens to CD4 T cells.

104 ells (DCs) phagocytose, process, and present bacterial antigens to T lymphocytes to trigger adaptive

105 IBD results from environmental factors (eg, bacterial antigens) triggering a dysregulated immune res

106 ed for exogenous presentation of nonsecreted bacterial antigens via its capacity to upregulate the ex

107 Plasmacytoid dendritic cells, activated by bacterial antigens via TLR9 or by viral infection, did n

108 This bacterial antigen was identified in a murine model and h

109 Modest translocation of bacteria/bacterial antigen was observed across the colonic epithe

110 IgE reactivity to bacterial antigens was significantly more frequent in pa

111 The targeted bacterial antigens were CFA/I fimbriae, flagella, lipopo

112 Antibodies to BPI and bacterial antigens were measured in sera by ELISA from f

113 osis by serological studies and detection of bacterial antigen within plaque.